Neutral
Last updated: 2026-10-06 05:24:58 ET
Can Nvidia hit $6 trillion? Wedbush's Matt Bryson on memory, open-weight AI and Intel
After months of testing, this high-end smart scale has made me rethink how much a bathroom weigh-in can tell me.
Fewer orders and higher costs are squeezing restaurants big and small as people on the weight-loss drugs eat and drink less when dining out.
Elevance Health has delivered a 12.4% gain over the past year, even as shorter term moves have been choppy, and that raises a simple question for you ...
NextEra Energy has delivered a 3 year share price gain that would have materially changed the experience of long term holders, which raises a simple q...
AI decision model Strands Decider 2B, released October 1 by AWS Strands Labs, is the first fully open-source entry in the emerging decision-model infr...
Runway, one of the best-known developers of generative AI video technology, is moving into robotics with Praxis-1, an open-weight AI model designed to...
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gound...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE